Is Medicon Hellas SA halal to invest in?

As of August 2026, Medicon Hellas SA MEDIC.AT is classified as not covered according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.

Is Medicon Hellas SA a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Medicon Hellas SA using these criteria to determine its compliance status.

Can Muslims buy shares of Medicon Hellas SA?

Muslim investors may consider investing in Medicon Hellas SA if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Medicon Hellas SA classified as NOT COVERED?

Musaffa determines the Shariah status of Medicon Hellas SA by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Medicon Hellas SA updated?

The Shariah compliance status of Medicon Hellas SA may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Medicon Hellas SA become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Medicon Hellas SA?

You can check the latest Shariah compliance status of Medicon Hellas SA on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Medicon Hellas SA MEDIC.AT

Last Updated: Aug 07, 12:00 AM·ASE

Medicon Hellas SA. Stock Analysis MEDIC.AT

Greece Health Care Nano Cap

Medicon Hellas SA engages in the business of medical technology. The company is headquartered in Athina, Attiki. The company went IPO on 2001-07-11. Its activities include research and development, production, and import and export of diagnostic products; the development of laboratory information systems; the import and distribution of in vitro diagnostics and automated analytical systems, such as Olympus for clinical chemistry, immunochemistry and lab automation, and Nihon Kohden for hematology, and the provision of cosmetic and body care products, such as make-up, anti-ageing and skin care products under the brand name Miss Beaute. Its laboratory information systems products include: Gi-Lab, which is a management system for medical laboratories; Gi-Maxima, a management program for medical centers, and Gi-Blood, which is an application that helps to connect various blood donation networks. On December 6, 2013, it merged by absorption of its subsidiary, Medicon Ltd.